机器人辅助肾部分切除术手术策略的影响:前侧肿瘤经腹腔入路与后侧肿瘤经腹膜后入路是否有益?
本研究基于1169例cT1-2N0M0患者的多中心数据,比较经腹腔机器人辅助肾部分切除术(tRAPN)与经腹膜后机器人辅助肾部分切除术(rRAPN)的围手术期并发症、功能及病理结局,并检验前侧肿瘤用tRAPN、后侧肿瘤用rRAPN是否更优。结果显示两种入路在并发症、手术时间、住院时间、缺血时间、1年eGFR及切缘阳性方面无差异,交互检验未发现肿瘤位置与入路存在获益交互。
要点
- tRAPN与rRAPN在并发症、手术时间、住院时间、缺血时间、1年eGFR及切缘阳性方面无显著差异。
- rRAPN较tRAPN估计失血量中位数更低(50 vs 100 ml),术后eGFR中位数更高(82 vs 78 ml/min/1.73 m2)。
- 交互检验未显示前侧肿瘤用tRAPN或后侧肿瘤用rRAPN在并发症、热缺血时间、术后eGFR及切缘阳性方面有优势。
核心结论
- rRAPN与tRAPN提供等效的围手术期并发症、功能及病理结局,与肿瘤位置无关。
研究设计与样本
- 基于1169例cT1-2N0M0患者的大型全球协作数据集,采用倾向性评分匹配及逻辑回归和线性回归分析。
主要发现
- rRAPN与tRAPN在并发症、手术时间、住院时间、缺血时间、中位1年eGFR及切缘阳性方面均无差异(所有p>0.05)。
- rRAPN与tRAPN的中位估计失血量分别为50 vs 100 ml(p<0.0001),术后eGFR分别为82 vs 78 ml/min/1.73 m2(p=0.04)。
- 交互检验显示前侧肿瘤tRAPN与后侧肿瘤rRAPN在并发症、热缺血时间、术后eGFR及切缘阳性方面均无优势(所有p>0.05)。
临床怎么用
- 机器人辅助肾部分切除术可根据术者习惯和肿瘤特征选择经腹腔或经腹膜后入路,无需仅因肿瘤前侧或后侧位置而强制特定入路。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Available comparison of transperitoneal robot-assisted partial nephrectomy (tRAPN) and retroperitoneal robot-assisted partial nephrectomy (rRAPN) does not consider tumour's location. The aim of this study was to compare perioperative morbidity, and functional and pathological outcomes after tRAPN and rRAPN, with the specific hypothesis that tRAPN for anterior tumours and rRAPN for posterior tumours might be a beneficial strategy. A large global collaborative dataset of 1169 cT1-2N0M0 patients was used. Propensity score matching, and logistic and linear regression analyses tested the effect of tRAPN versus rRAPN on perioperative outcomes. No differences were observed between rRAPN and tRAPN with respect to complications, operative time, length of stay, ischaemia time, median 1-yr estimated glomerular filtration rate (eGFR), and positive surgical margins (all p>0.05). Median estimated blood loss and postoperative eGFR were 50 versus100ml (p<0.0001) and 82 versus 78ml/min/1.73 m2 (p=0.04) after rRAPN and tRAPN, respectively. At interaction tests, no advantage was observed after tRAPN for anterior tumours and rRAPN for posterior tumours with respect to complications, warm ischaemia time, postoperative eGFR, and positive surgical margins (all p>0.05). The techniques of rRAPN and tRAPN offer equivalent perioperative morbidity, and functional and pathological outcomes, regardless of tumour's location. PATIENT SUMMARY: Robot-assisted partial nephrectomy can be performed with a transperitoneal or a retroperitoneal approach regardless of the specific position of the tumour, with equivalent outcomes for the patient.
引用
- Dell'Oglio P, De Naeyer G, Xiangjun L, et al. The Impact of Surgical Strategy in Robot-assisted Partial Nephrectomy: Is It Beneficial to Treat Anterior Tumours with Transperitoneal Access and Posterior Tumours with Retroperitoneal Access? Eur Urol Oncol. 2019. PMID: 31411997. doi:10.1016/j.euo.2018.12.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。